Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 (original) (raw)
- Letter
- Published: 16 January 2002
- Nikolai B. Federov1 nAff5,
- Jeff H. Kogan1 nAff5,
- Geoffrey G. Murphy1,
- Joel Stern1,
- Masuo Ohno1,
- Raju Kucherlapati2,
- Tyler Jacks nAff4 &
- …
- Alcino J. Silva1
Nature volume 415, pages 526–530 (2002)Cite this article
- 4128 Accesses
- 443 Citations
- 4 Altmetric
- Metrics details
Abstract
Neurofibromatosis type I (NF1) is one of the most common single-gene disorders that causes learning deficits in humans1. Mice carrying a heterozygous null mutation of the Nf1 gene (Nf1+/−) show important features of the learning deficits associated with NF1 (ref. 2). Although neurofibromin has several known properties and functions, including Ras GTPase-activating protein activity3,4, adenylyl cyclase modulation5,6 and microtubule binding7, it is unclear which of these are essential for learning in mice and humans. Here we show that the learning deficits of Nf1+/− mice can be rescued by genetic and pharmacological manipulations that decrease Ras function. We also show that the Nf1+/− mice have increased GABA (γ-amino butyric acid)-mediated inhibition and specific deficits in long-term potentiation, both of which can be reversed by decreasing Ras function. Our results indicate that the learning deficits associated with NF1 may be caused by excessive Ras activity, which leads to impairments in long-term potentiation caused by increased GABA-mediated inhibition. Our findings have implications for the development of treatments for learning deficits associated with NF1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- North, K. Neurofibromatosis type 1. Am. J. Med. Genet. 97, 119–127 (2000)
Article CAS Google Scholar - Silva, A. J. et al. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nature Genet. 15, 281–284 (1997)
Article CAS Google Scholar - Ballester, R. et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851–859 (1990)
Article CAS Google Scholar - Xu, G. F. et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63, 835–841 (1990)
Article CAS Google Scholar - Guo, H. F., The, I., Hannan, F., Bernards, A. & Zhong, Y. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 276, 795–798 (1997)
Article CAS Google Scholar - Guo, H. F., Tong, J., Hannan, F., Luo, L. & Zhong, Y. A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 403, 895–898 (2000)
Article ADS CAS Google Scholar - Xu, H. & Gutmann, D. H. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res. 759, 149–152 (1997)
Article CAS Google Scholar - Ozonoff, S. Cognitive impairment in neurofibromatosis type 1. Am. J. Med. Genet. 89, 45–52 (1999)
Article CAS Google Scholar - Morris, R. G., Garrud, P., Rawlins, J. N. & O'Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature 297, 681–683 (1982)
Article ADS CAS Google Scholar - Costa, R. M. et al. Learning deficits, but normal development and tumour predisposition, in mice lacking exon 23a of Nf1. Nature Genet. 27, 399–405 (2001)
Article CAS Google Scholar - Klose, A. et al. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum. Mol. Genet. 7, 1261–1268 (1998)
Article CAS Google Scholar - Johnson, L. K-r. et al. ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11, 2468–2481 (1997)
Article CAS Google Scholar - Brannan, C. I. et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev. 8, 1019–1029 (1994)
Article ADS CAS Google Scholar - Brandeis, R., Brandys, Y. & Yehuda, S. The use of the Morris water maze in the study of memory and learning. Int. J. Neurosci. 48, 29–69 (1989)
Article CAS Google Scholar - Gallagher, M., Burwell, R. & Burchinal, M. Severity of spatial learning impairment in aging: Development of a learning index for performance in the Morris water maze. Behav. Neurosci. 107, 618–626 (1993)
Article CAS Google Scholar - Muthalif, M. M. et al. Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension. Hypertension 35, 457–463 (2000)
Article CAS Google Scholar - Gibbs, J. B. et al. Farnesyltransferase inhibitors versus Ras inhibitors. Curr. Opin. Chem. Biol. 1, 197–203 (1997)
Article CAS Google Scholar - Yan, N. et al. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype. Cancer Res. 55, 3569–3575 (1995)
CAS PubMed Google Scholar - Kim, H. A., Ling, B. & Ratner, N. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase. Mol. Cell. Biol. 17, 862–872 (1997)
Article CAS Google Scholar - Abbott, L. F. & Nelson, S. B. Synaptic plasticity: taming the beast. Nature Neurosci. 3, 1178–1183 (2000)
Article CAS Google Scholar - Larson, J., Wong, D. & Lynch, G. Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res. 368, 347–350 (1986)
Article CAS Google Scholar - Hessler, N. A., Shirke, A. M. & Malinow, R. The probability of transmitter release at a mammalian central synapse. Nature 366, 569–572 (1993)
Article ADS CAS Google Scholar - Chapman, C. A., Perez, Y. & Lacaille, J. C. Effects of GABAA inhibition on the expression of long-term potentiation in CA1 pyramidal cells are dependent on tetanization parameters. Hippocampus 8, 289–298 (1998)
Article CAS Google Scholar - Chorvatova, A., Gendron, L., Bilodeau, L., Gallo-Payet, N. & Payet, M. D. A Ras-dependent chloride current activated by adrenocorticotropin in rat adrenal zona glomerulosa cells. Endocrinology 141, 684–692 (2000)
Article CAS Google Scholar - Tong, J. et al. NF1-regulated adenylyl cyclase pathway. Soc. Neurosci. Abstr. abstract no. 345.9 (Society for Neuroscience, New Orleans, 2000).
- Ingram, D. A. et al. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J. Exp. Med. 194, 57–69 (2001)
Article CAS Google Scholar - Jacks, T. et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet. 7, 353–361 (1994)
Article CAS Google Scholar - Umanoff, H., Edelmann, W., Pellicer, A. & Kucherlapati, R. The murine N-ras gene is not essential for growth and development. Proc. Natl Acad. Sci. USA 92, 1709–1713 (1995)
Article ADS CAS Google Scholar - Voikar, V., Koks, S., Vasar, E. & Rauvala, H. Strain and gender differences in the behaviour of mouse lines commonly used in transgenic studies. Physiol. Behav. 72, 271–281 (2001)
Article CAS Google Scholar - Blanton, M. G., Lo Turco, J. J. & Kriegstein, A. R. Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Methods 30, 203–210 (1989)
Article CAS Google Scholar
Acknowledgements
We thank V. Manne for the BMS191563, and E. Friedman for technical assistance in earlier experiments. We are grateful to M. Barad, D. Buonomano, T. Cannon, J. Colicelli, P. Frankland, L. Kaczmarek, A. Matynia, M. Sanders and D. Smith for discussions, and to C. Brannan and S. Schlussel for encouragement. R.M.C. received support from the Graduated Program in Basic and Applied Biology (GABBA) of the University of Oporto, the Portuguese Foundation for Science and Technology (FCT) and the National Neurofibromatosis Foundation (NNF). This work was also supported by a generous donation from K. M. Spivak, and by grants from the NIH, Neurofibromatosis Inc. (National, Illinois, Mass Bay Area, Minnesota, Arizona, Kansas and Central Plains, Mid-Atlantic, and Texas chapters), the Merck and the NNF foundations to A.J.S.
Author information
Author notes
- Tyler Jacks
Present address: Department of Biology, Massachusetts Institute of Technology, Cambridge, 02139, Massachusetts, USA - Nikolai B. Federov & Jeff H. Kogan
Present address: Memory Pharmaceuticals Corporation, 100 Philips Parkway, Montvale, New Jersey, 07645, USA
Authors and Affiliations
- Departments of Neurobiology, Psychiatry and Psychology, BRI, University of California at Los Angeles, Los Angeles, California, 90095-1761, USA
Rui M. Costa, Nikolai B. Federov, Jeff H. Kogan, Geoffrey G. Murphy, Joel Stern, Masuo Ohno & Alcino J. Silva - Department of Molecular Genetics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 10461, New York, USA
Raju Kucherlapati
Authors
- Rui M. Costa
You can also search for this author inPubMed Google Scholar - Nikolai B. Federov
You can also search for this author inPubMed Google Scholar - Jeff H. Kogan
You can also search for this author inPubMed Google Scholar - Geoffrey G. Murphy
You can also search for this author inPubMed Google Scholar - Joel Stern
You can also search for this author inPubMed Google Scholar - Masuo Ohno
You can also search for this author inPubMed Google Scholar - Raju Kucherlapati
You can also search for this author inPubMed Google Scholar - Tyler Jacks
You can also search for this author inPubMed Google Scholar - Alcino J. Silva
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toAlcino J. Silva.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Costa, R., Federov, N., Kogan, J. et al. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.Nature 415, 526–530 (2002). https://doi.org/10.1038/nature711
- Received: 10 August 2001
- Accepted: 21 November 2001
- Published: 16 January 2002
- Issue Date: 31 January 2002
- DOI: https://doi.org/10.1038/nature711